BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10650928)

  • 1. Selective impairment of corticotropin-releasing factor1 (CRF1) receptor-mediated function using CRF coupled to saporin.
    Maciejewski-Lenoir D; Heinrichs SC; Liu XJ; Ling N; Tucker A; Xie Q; Lappi DA; Grigoriadis DE
    Endocrinology; 2000 Feb; 141(2):498-504. PubMed ID: 10650928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA; Trinh JV; Myers TR
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
    Oshida Y; Ikeda Y; Chaki S; Okuyama S
    Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
    Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
    Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
    J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells.
    Schoeffter P; Feuerbach D; Bobirnac I; Gazi L; Longato R
    Fundam Clin Pharmacol; 1999; 13(4):484-9. PubMed ID: 10456290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
    Mansi JA; Rivest S; Drolet G
    Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response.
    Ising M; Zimmermann US; Künzel HE; Uhr M; Foster AC; Learned-Coughlin SM; Holsboer F; Grigoriadis DE
    Neuropsychopharmacology; 2007 Sep; 32(9):1941-9. PubMed ID: 17287823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors.
    Gaillard RC; Turnill D; Sappino P; Muller AF
    Endocrinology; 1990 Jul; 127(1):101-6. PubMed ID: 2163305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of the adrenocorticotropin secretory responses to corticotropin-releasing factor (CRF) and vasopressin or oxytocin by using a specific cytotoxic analog of CRF.
    Schwartz J; Vale W
    Endocrinology; 1988 Apr; 122(4):1695-700. PubMed ID: 2831039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional CRF receptors in BON cells stimulate serotonin release.
    von Mentzer B; Murata Y; Ahlstedt I; Lindström E; Martínez V
    Biochem Pharmacol; 2007 Mar; 73(6):805-13. PubMed ID: 17184738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.